Bank of America’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-65,327
Closed -$248K 6575
2020
Q1
$248K Sell
65,327
-459,343
-88% -$1.74M ﹤0.01% 4420
2019
Q4
$2.67M Buy
524,670
+288,390
+122% +$1.47M ﹤0.01% 3258
2019
Q3
$1.2M Sell
236,280
-138,225
-37% -$699K ﹤0.01% 3763
2019
Q2
$2.31M Sell
374,505
-322,303
-46% -$1.99M ﹤0.01% 3366
2019
Q1
$3.23M Buy
696,808
+549,839
+374% +$2.55M ﹤0.01% 3098
2018
Q4
$616K Sell
146,969
-82,212
-36% -$345K ﹤0.01% 4140
2018
Q3
$1.44M Sell
229,181
-47,990
-17% -$301K ﹤0.01% 3638
2018
Q2
$2.23M Sell
277,171
-118,099
-30% -$950K ﹤0.01% 3356
2018
Q1
$2.95M Buy
395,270
+142,784
+57% +$1.07M ﹤0.01% 3093
2017
Q4
$1.5M Sell
252,486
-330,698
-57% -$1.97M ﹤0.01% 3568
2017
Q3
$4.29M Buy
583,184
+173,589
+42% +$1.28M ﹤0.01% 2866
2017
Q2
$2.78M Buy
409,595
+26,415
+7% +$179K ﹤0.01% 3081
2017
Q1
$3.62M Buy
383,180
+81,852
+27% +$773K ﹤0.01% 2859
2016
Q4
$2.6M Buy
301,328
+291,343
+2,918% +$2.52M ﹤0.01% 3016
2016
Q3
$64K Sell
9,985
-7,153
-42% -$45.8K ﹤0.01% 4882
2016
Q2
$73K Buy
17,138
+10,138
+145% +$43.2K ﹤0.01% 4891
2016
Q1
$31K Sell
7,000
-12,825
-65% -$56.8K ﹤0.01% 5144
2015
Q4
$122K Sell
19,825
-6,837
-26% -$42.1K ﹤0.01% 4701
2015
Q3
$152K Sell
26,662
-80,134
-75% -$457K ﹤0.01% 4517
2015
Q2
$797K Buy
106,796
+75,780
+244% +$566K ﹤0.01% 3462
2015
Q1
$186K Sell
31,016
-11,844
-28% -$71K ﹤0.01% 4058
2014
Q4
$325K Sell
42,860
-23,518
-35% -$178K ﹤0.01% 3860
2014
Q3
$344K Sell
66,378
-50,345
-43% -$261K ﹤0.01% 3738
2014
Q2
$504K Sell
116,723
-18,944
-14% -$81.8K ﹤0.01% 3504
2014
Q1
$554K Sell
135,667
-12,850
-9% -$52.5K ﹤0.01% 3465
2013
Q4
$791K Buy
148,517
+33,543
+29% +$179K ﹤0.01% 3315
2013
Q3
$577K Buy
114,974
+3,668
+3% +$18.4K ﹤0.01% 3387
2013
Q2
$497K Buy
+111,306
New +$497K ﹤0.01% 3716